Pharmacotherapeutic efficiency and advantages of the combined treatment of patients with type 2 diabetes mellitus
Journal Title: Міжнародний ендокринологічний журнал - Year 2017, Vol 13, Issue 6
Abstract
Background. The early prescription of a combination of extended-release metformin with glimepiride influencing different links of the pathogenesis of type 2 diabetes mellitus (DM) is grounded in the article. The purpose of the research was to evaluate the dynamics of glycated haemoglobin (HbA1c) after the period of supervision as compared to the baseline, and also to determine additional parameters of efficiency, safety, and tolerability of Duglimax manufactured by Кusum Pharm (Ukraine) in the therapy of type 2 DM. Materials and methods. The study included 46 patients with type 2 DM divided into two groups. For the patients of the first group (n = 26), who previously received metformin preparations at a dose of up to 2000 mg/day, the combined preparation Duglimax (metformin 500 mg and glimepiride 2 mg) was prescribed, and also extended-release metformin (Metamin SR) in the evening. The patients of the second group (n = 20) continued the reception of extended-release metformin twice daily in a dose of 2000–2500 mg/day. Results. After 12 weeks of therapy, in patients of the first group, the level of НbА1с significantly decreased to 6.72 ± 0.29 %. The level of insulin in the first group was 14.06 ± 1.81 mIU/ml after treatment (in baseline level of 19.17 ± 2.05 mIU/ml), HOMA-IR — 3.14 ± 0.21 (vs initial one of 5.92 ± 1.46). Results of the clinical study show the absence of hypoglycemia development in patients receiving Duglimax during the follow-up period. Conclusions. Combined antidiabetic therapy with Duglimax for 12 weeks results in the substantial decrease of HbA1c level and achievement of target indexes of carbohydrate metabolism in type 2 DM patients. The good tolerability and high safety of Duglimax were registered during the period of supervision.
Authors and Affiliations
V. I. Pankiv
Keywords
Related Articles
- EP ID EP231286
- DOI 10.22141/2224-0721.13.6.2017.112887
- Views 57
- Downloads 0
Primary Hyperparathyroidism: Etiology, Pathogenesis, Clinical Picture, Diagnosis, Treatment, Quality of Life (Review of Literature)
The author provide a literature review of the data for the last 10–15 years on the problem of primary hyperparathyroidism (PHPT). PHPT was first described in 1943, but interest to the diseases of the parathyroid glands g...
Reproductive Function Disorders in Women with Thyroid Dysfunction (Review of the Problem)
The article provides the information on the prevalence in the population and the impact on female reproductive function of diseases associated with thyroid hypofunction. The authors analyzed the literature on this issue....
Efficiency of Alpha Lipoic Acid Therapy at Diabetic Foot Syndrome
The article deals with increasing the effectiveness of treatment of patients with diabetes mellitus with diabetic foot syndrome (DFS) by applying the integrated treatment with α-lipoic acid. We evaluated the clinical eff...
Autoimmune polyglandular syndrome type 2 (clinical case of Сarpenter syndrome)
Carpenter syndrome is a rare autoimmune disease that is associated with impaired function of several endocrine organs (diabetes mellitus, chronic adrenal insufficiency and/or autoimmune thyroiditis). A case of atypical c...
Clinical experience of using herbal medicinal product Glucemedin in the comprehensive treatment of patients with type 2 diabetes mellitus
Background. The current task of treating patients with type 2 diabetes mellitus and dyslipoproteinemia is the analysis of efficiency of the combination of standard hypoglycemic agents with phytotherapeutic drugs, but inf...